Predicting prognosis in acute liver failure: Ammonia and the risk of cerebral edema

Hepatology

Volumn 46, Issue 6, 2007, Pages 1679-1681

  Davern, Timothy J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ANTIBIOTIC AGENT; ANTINEOPLASTON AS2-1; BENZOIC ACID; LACTULOSE; LAXATIVE; RIFAXIMIN;

BRAIN EDEMA; BRAIN HERNIA; CHRONIC LIVER DISEASE; CORRELATION ANALYSIS; DISEASE COURSE; EDITORIAL; HEPATIC ENCEPHALOPATHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFORMATION PROCESSING; INTRACRANIAL HYPERTENSION; LIVER FAILURE; LIVER TRANSPLANTATION; MORBIDITY; MULTIPLE ORGAN FAILURE; PATIENT CARE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURGICAL TECHNIQUE;

AMMONIA; BRAIN EDEMA; HUMANS; LIVER FAILURE, ACUTE; PROGNOSIS;

EID: 37749017594     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22038     Document Type: Editorial

References (12)

1. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970;3:282-298.
2. Felipo V, Butterworth RF. Neurobiology of ammonia. Prog Neurobiol 2002;67:259-279.
3. Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci 2005;62:2295-2304.
4. Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. HEPATOLOGY 2006;44:788-794.
5. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. HEPATOLOGY 1999;29:648-653.
6. Bhatia V, Singh R, Acharya SK. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 2006;55:98-104.
7. Ong JP, Aggarwal A, Krieger D, Easley KA, Karafa MT, Van Lente F, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 2003;114:188-193.
8. Kundra A, Jain A, Banga A, Bajaj G, Kar P. Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension. Clin Biochem 2005;38:696-699.
9. Vaquero J, Fontana RJ, Larson AM, Bass NM, Davern TJ, Shakil AO, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 2005;11:1581-1589.
10. Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007;13:1174-1180.
11. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005;11:336-343.
12. Bernal N, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. HEPATOLOGY 2007;46. DOI: 10.1002/hep.21838.